mRNA based therapeutics
Sapientis establishes unique ecosystem for mRNA-based therapies within Central Europe
Our aspiration is to build a new type of platform-based biotech company that offers its services not only to established companies, but also to pharma / biotech start-ups
A disruptive drug platform: carefully designed molecules called messenger RNA that prompt the body to make its own medicine.
Used by all living things to make proteins, messenger RNA is one of the least explored frontiers of drug discovery.
Cells use mRNA to translate the static genes of DNA into dynamic proteins, involved in every bodily function.
We aspire to enable biopharma companies to exceed their goals in developing and delivering life-transforming nucleic-acid therapies, through production and GMP manufacturing of biopharmaceutical drug substances.
Global academic and industry collaborations are supporting sapientis in establishing a premier ecosystem to enable scientific progress and shared learning to speed up the availability of biotechnological solutions. Application include infectious diseases, immunotherapies against cancer, and precision medicine in rare diseases. Pilot projects will deliver products for clinical trial activities.